These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10639300

  • 1. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women.
    Fak AS, Erenus M, Tezcan H, Caymaz O, Atagündüz P, Oktay S, Oktay A.
    Eur Heart J; 2000 Feb; 21(3):190-7. PubMed ID: 10639300
    [Abstract] [Full Text] [Related]

  • 2. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM, Johns JA, McCloud PI, Davis SR.
    N Engl J Med; 1997 Aug 28; 337(9):595-601. PubMed ID: 9271481
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.
    Averbuch M, Ayalon D, Eckstein N, Dotan I, Shapira I, Levo Y, Pines A.
    J Med; 1998 Aug 28; 29(5-6):343-50. PubMed ID: 10503169
    [Abstract] [Full Text] [Related]

  • 4. Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
    Insull W, Davidson MH, Kulkarni PM, Siddhanti S, Ciaccia AV, Keech CA.
    Metabolism; 2005 Jul 28; 54(7):939-46. PubMed ID: 15988705
    [Abstract] [Full Text] [Related]

  • 5. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 28; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 28; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 7. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 28; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 28; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul 28; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 28; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 11. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K.
    Metabolism; 2000 Jun 28; 49(6):784-9. PubMed ID: 10877207
    [Abstract] [Full Text] [Related]

  • 12. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 28; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 13. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Jul 28; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 14. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 28; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 28; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 16. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 28; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 17. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T, Koren M, Insull W, McKenney J, Schrott H, Lewin A, Shah S, Sidisin M, Cho M, Kush D, Mitchel Y.
    Am J Cardiol; 2004 Jun 15; 93(12):1481-6. PubMed ID: 15194017
    [Abstract] [Full Text] [Related]

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 19. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Jun 15; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 20. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
    Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR.
    Am J Cardiol; 2008 Aug 15; 102(4):429-33. PubMed ID: 18678300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.